Swiss pharmaceutical and biotech giant Roche has acquired Madison-based Mirus Bio Corp. for $125 million, the two companies announced Tuesday.
Mirus Bio is a leader in RNAi (ribonucleic acid interference) technology, a method of determining how genes are turned off and on in cells, with new medicines emerging from RNAi that could prevent disease-causing proteins from being made.
According to a press release from Mirus Bio, Roche will maintain the RNAi research site in Madison.
(Mirus Bio Corp. was founded in 1995 by Dr. Jon Wolff and his colleagues James Hagstrom and the late Vladimir Budker.)